A Study of LY3202626 in Healthy Participants

Summary

The purposes of this study are to determine: * If there are any differences in the way LY3202626 is handled by the body when taken in two different forms * Whether a high fat meal affects the way the body handles LY3202626 * How well tolerated LY3202626 is There are three (3) study periods for all participants. Participants will be admitted to the clinical research unit (CRU) each period and will be discharged from the CRU following the completion of 2 overnight stays and up to 36 hours after dosing with LY3202626. The study will last about 50 days, not including screening.

Timeline

Start

2017-01-15

Primary completion

2017-04-04

Completion

2017-04-04

Drugs

Indications

No indication recorded.